Generic Drugs Deserve No Greater Protection than Name-Brand Drugs
In a recent editorial piece, the New York Times articulated what injured victims and plaintiffs lawyers have been saying for the last year – Congress should not allow generic drug manufacturers special protections when those manufacturers fail to warn patients of the generic drug’s dangers. Last year, the United States Supreme Court ruled that although…
Read More